Home › Companies › VIKING THERAPEUTICS INC. › 2024-2025
Compiled from SEC Form N-PX filings and VIKING THERAPEUTICS INC.’s Form 8-K, filed May 27, 2025 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of May 20, 2025: 4 items on VIKING THERAPEUTICS INC.’s Form 8-K, filed May 27, 2025: 2 approved · 2 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore VIKING THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are VIKING THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 27, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Matthew W. Foehr | 28,050,978 | -- | -- | 16,211,847 | 32,427,944 | 63% | Not verified | — |
| Elect Director: Charles A. Rowland, Jr. | 32,982,998 | -- | -- | 11,279,827 | 32,427,944 | 75% | Not verified | — |
| 2. To ratify the selection of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025 | 75,225,572 | 992,111 | 473,085 | -- | -- | 99% | Approved | — |
| 3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement | 29,265,273 | 14,490,719 | 506,834 | -- | 32,427,943 | 67% | Approved | — |
Source: VIKING THERAPEUTICS INC., Form 8-K, filed with the SEC on May 27, 2025 — read the filing on EDGAR.
Each item below shows how the 402 asset managers that disclosed a VIKING THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 7 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTOR NOMINEES FOR CLASS I (term to expire in 2028): Charles A. Rowland, Jr.
VIKING THERAPEUTICS INC.’s own tally for this item (“Elect Director: Charles A. Rowland, Jr.”): 32,982,998 for, 11,279,827 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 78 asset managers below reported 17,191,595 for, 5,547,885 withheld, 152,582 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,303,687 | 0 | 4 | 0 | For |
| Fidelity | 746,449 | 0 | 0 | 3,323,153 | Mixed |
| JPMorgan | 1,612,333 | 0 | 0 | 0 | For |
| BlackRock | 1,221,928 | 0 | 0 | 0 | For |
| Charles Schwab | 709,625 | 0 | 0 | 0 | For |
| State Street | 408,037 | 0 | 0 | 486 | For |
| Delaware/Macquarie | 0 | 0 | 0 | 330,100 | Withhold |
| Columbia Threadneedle | 313,359 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 304,627 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 295,481 | Withhold |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 287,965 | Withhold |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 258,600 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 256,780 | Withhold |
| MUTUAL FUND SERIES TRUST | 255,407 | 0 | 0 | 0 | For |
| Legg Mason | 240,200 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 236,880 | 0 | 0 | 0 | For |
| Putnam | 198,320 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 159,860 | Withhold |
| Equitable | 7,215 | 0 | 0 | 115,438 | Mixed |
| Harbor Funds II | 115,189 | 0 | 0 | 0 | For |
| Northwestern Mutual | 100,328 | 0 | 0 | 0 | For |
| Russell Investments | 94,493 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 80,594 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 80,058 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 74,811 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 7 wordings of this item as funds reported it.
63% Majority: yes · of votes cast
Description as filed by funds: ELECTION OF DIRECTOR NOMINEES FOR CLASS I (term to expire in 2028): Matthew W. Foehr
VIKING THERAPEUTICS INC.’s own tally for this item (“Elect Director: Matthew W. Foehr”): 28,050,978 for, 16,211,847 withheld, per its Form 8-K filed May 27, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 63% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 78 asset managers below reported 15,439,339 for, 5,969,114 withheld, 1,483,608 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,303,686 | 0 | 4 | 0 | For |
| Fidelity | 700,350 | 0 | 0 | 3,369,252 | Mixed |
| JPMorgan | 1,612,333 | 0 | 0 | 0 | For |
| BlackRock | 0 | 0 | 1,221,928 | 0 | Abstain |
| Charles Schwab | 709,625 | 0 | 0 | 0 | For |
| State Street | 1,008 | 0 | 0 | 407,515 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 330,100 | Withhold |
| Columbia Threadneedle | 313,359 | 0 | 0 | 0 | For |
| Principal | 0 | 0 | 0 | 304,627 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 295,481 | Withhold |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 287,965 | Withhold |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 258,600 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 256,780 | Withhold |
| MUTUAL FUND SERIES TRUST | 255,407 | 0 | 0 | 0 | For |
| Legg Mason | 240,200 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 236,880 | 0 | 0 | 0 | For |
| Putnam | 198,320 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 159,860 | Withhold |
| Equitable | 0 | 0 | 0 | 122,653 | Withhold |
| Harbor Funds II | 115,189 | 0 | 0 | 0 | For |
| Northwestern Mutual | 100,328 | 0 | 0 | 0 | For |
| Russell Investments | 94,493 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 80,594 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 80,058 | 0 | Abstain |
| BARON SELECT FUNDS | 74,811 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 10 wordings of this item as funds reported it.
67% Approved · of votes cast
Description as filed by funds: TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS.
VIKING THERAPEUTICS INC.’s own tally for this item (“3. To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement”): 29,265,273 for, 14,490,719 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “As a result, the Company's stockholders voted to approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.”
Support: 67% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of VIKING THERAPEUTICS INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “COMPENSATION” (2 managers, 42 for); “Say on pay” (2 managers, 183 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,302,209 | 1,482 | 0 | 0 | For |
| Fidelity | 3,330,879 | 738,723 | 0 | 0 | Mixed |
| JPMorgan | 1,612,333 | 0 | 0 | 0 | For |
| BlackRock | 1,221,928 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 709,625 | 0 | 0 | Against |
| State Street | 408,037 | 486 | 0 | 0 | For |
| Delaware/Macquarie | 0 | 330,100 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 313,359 | 0 | 0 | Against |
| Principal | 53,327 | 251,300 | 0 | 0 | Mixed |
| AllianceBernstein | 295,481 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 287,965 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 0 | 258,600 | 0 | 0 | Against |
| Voya | 256,780 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 255,407 | 0 | Abstain |
| Legg Mason | 240,200 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 0 | 236,880 | 0 | 0 | Against |
| Putnam | 0 | 198,320 | 0 | 0 | Against |
| TIAA | 159,860 | 0 | 0 | 0 | For |
| Equitable | 122,653 | 0 | 0 | 0 | For |
| Harbor Funds II | 115,189 | 0 | 0 | 0 | For |
| Northwestern Mutual | 100,328 | 0 | 0 | 0 | For |
| Russell Investments | 94,493 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 80,594 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 80,058 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 0 | 74,811 | 0 | 0 | Against |
Fund voting reports, all 79 managers: 18,909,714 for, 3,684,346 against, 265,910 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Fidelity | 5,589,957 | 0 | 0 | 0 | For |
| BlackRock | 2,598,943 | 29,667 | 0 | 0 | For |
| JPMorgan | 1,994,723 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 0 | 1,714,062 | 0 | 0 | Against |
| State Street | 1,068,483 | 11,254 | 0 | 0 | For |
| AMERIPRISE FINANCIAL INC | 0 | 1,025,604 | 0 | 0 | Against |
| AllianceBernstein | 920,693 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 715,823 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 707,201 | 0 | 0 | Against |
| PNC BANK, NATIONAL ASSOCIATION | 656,037 | 0 | 0 | 0 | For |
| Clearbridge Investments, LLC | 631,764 | 0 | 0 | 0 | For |
| BRAIDWELL LP | 0 | 443,354 | 0 | 0 | Against |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | 393,849 | 0 | 0 | Against |
| BAMCO INC /NY/ | 0 | 387,319 | 0 | 0 | Against |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 376,556 | 0 | 0 | Against |
| PRINCIPAL GLOBAL INVESTORS | 0 | 363,579 | 0 | 0 | Against |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 330,100 | 0 | 0 | Against |
| Voya | 256,780 | 47,179 | 0 | 0 | Mixed |
| Northern Trust | 264,839 | 10,536 | 0 | 0 | For |
| BLAIR WILLIAM & CO/IL | 0 | 273,909 | 0 | 0 | Against |
| Vanguard | 255,859 | 7,784 | 0 | 0 | For |
| WASATCH ADVISORS LP | 0 | 257,448 | 0 | 0 | Against |
| UBS | 0 | 241,129 | 0 | 0 | Against |
| Fiera Capital Corp | 0 | 223,824 | 0 | 0 | Against |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 111,657 | 111,657 | 0 | 0 | Mixed |
Institutional-manager reports, all 338 managers: 16,732,532 for, 10,326,566 against, 146,973 withheld, 7,913 abstained, 752 not voted. Showing the 25 largest; see all in the interactive database.
Combines 5 wordings of this item as funds reported it.
99% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE SELECTION OF CBIZ CPAS P.C. AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR ITS FISCAL YEAR ENDING DECEMBER 31, 2025.
VIKING THERAPEUTICS INC.’s own tally for this item (“2. To ratify the selection of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025”): 75,225,572 for, 992,111 against — passed, per its Form 8-K filed May 27, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “As a result, the Company's stockholders voted to ratify the selection of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for its fiscal year ending December 31, 2025.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 82 asset managers below reported 22,829,823 for, 66,644 against, 10,503 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 10,303,691 | 0 | 0 | 0 | For |
| Fidelity | 4,069,602 | 0 | 0 | 0 | For |
| JPMorgan | 1,612,333 | 0 | 0 | 0 | For |
| BlackRock | 1,221,928 | 0 | 0 | 0 | For |
| Charles Schwab | 709,625 | 0 | 0 | 0 | For |
| State Street | 408,523 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 330,100 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 313,359 | 0 | 0 | 0 | For |
| Principal | 304,627 | 0 | 0 | 0 | For |
| AllianceBernstein | 295,481 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 287,965 | 0 | 0 | 0 | For |
| BARON INVESTMENT FUNDS TRUST (f/k/a BARON ASSET FUND) | 258,600 | 0 | 0 | 0 | For |
| Voya | 256,780 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 255,407 | 0 | 0 | 0 | For |
| Legg Mason | 240,200 | 0 | 0 | 0 | For |
| WASATCH FUNDS TRUST | 236,880 | 0 | 0 | 0 | For |
| Putnam | 198,320 | 0 | 0 | 0 | For |
| TIAA | 159,860 | 0 | 0 | 0 | For |
| Equitable | 122,653 | 0 | 0 | 0 | For |
| Harbor Funds II | 115,189 | 0 | 0 | 0 | For |
| Northwestern Mutual | 100,328 | 0 | 0 | 0 | For |
| Russell Investments | 94,493 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 80,594 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 80,058 | 0 | 0 | 0 | For |
| BARON SELECT FUNDS | 74,811 | 0 | 0 | 0 | For |
Showing the 25 largest of 82 asset managers. See all 82 in the interactive database.
Not shown here: this season’s fund filings also report 1 item from the meeting of May 21, 2024, which belongs to the 2023-2024 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 112,288,759 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.18% |
| 2 | Fidelity | 3.62% |
| 3 | JPMorgan | 1.44% |
| 4 | BlackRock | 1.09% |
| 5 | Charles Schwab | 0.63% |
| 6 | State Street | 0.36% |
| 7 | Delaware/Macquarie | 0.29% |
| 8 | Columbia Threadneedle | 0.28% |
| 9 | Principal | 0.27% |
| 10 | AllianceBernstein | 0.26% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Fidelity | 4.98% |
| 2 | BlackRock | 2.34% |
| 3 | JPMorgan | 1.78% |
| 4 | PICTET ASSET MANAGEMENT SA | 1.53% |
| 5 | State Street | 0.96% |
| 6 | AMERIPRISE FINANCIAL INC | 0.91% |
| 7 | AllianceBernstein | 0.82% |
| 8 | Charles Schwab | 0.64% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 0.63% |
| 10 | PNC BANK, NATIONAL ASSOCIATION | 0.58% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| FMR LLC | 13.36% | DEF14A |
| FMR (Fidelity) | 10.02% | 13F |
| Vanguard Group | 9.05% | 13F |
| BlackRock | 5.32% | 13F |
| State Street | 3.61% | 13F |
| Citadel Advisors | 3.40% | 13F |
| Brian Lian, Ph.D. | 2.91% | DEF14A |
| JPMorgan Chase | 2.78% | 13F |
| Morgan Stanley | 2.78% | 13F |
| Northern Trust | 0.48% | 13F |
Percentages above are of 112,288,759 shares outstanding, as reported by VIKING THERAPEUTICS INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from VIKING THERAPEUTICS INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At VIKING THERAPEUTICS INC.'s shareholder meeting held May 20, 2025, in the 2024-2025 proxy season, 402 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 1,526 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. — VIKING THERAPEUTICS INC.'s filing reports the proposal as approved, with 67% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: VIKING THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 27, 2025.
VIKING THERAPEUTICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.